Celularity Inc. (CELU)
NCM · Common · CUSIP 151190204
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CELU and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
151190204 (prev. 151190105 )
Market Cap
Small Cap
IPO
5/21/2019
Previous Symbol
GXGX
Previous Name
GX Acquisition Corp.
Business: Celularity Inc. is a clinical-stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases.

Company Contact

CEO
Robert J. Hariri
CFO
Joseph C. DosSantos
Headquarters
170 Park Ave, Florham Park, NJ 07932
Phone
908-768-2170
Investor Relations
Carlos Ramirez · Carlos.ramirez@celularity.com
SEC EDGAR Filings
View filings »